{"result": "(\"entity\"<|>TASK FORCE FOR THE REVISION OF SAFE PRACTICES FOR PARENTERAL NUTRITION<|>ORGANIZATION<|>A group focused on establishing safe practices for parenteral nutrition, ensuring the health and safety of patients receiving this treatment.)\n##\n(\"entity\"<|>INFECTIOUS DISEASES SOCIETY OF AMERICA<|>ORGANIZATION<|>A professional organization dedicated to the study and treatment of infectious diseases, providing guidelines and updates for clinical practices.)\n##\n(\"entity\"<|>SWITZERLAND<|>GEO<|>A country in Europe known for its healthcare system and practices, including those related to parenteral nutrition.)\n##\n(\"entity\"<|>FRANCE<|>GEO<|>A European country with healthcare practices that include parenteral nutrition, contributing to research and guidelines in this field.)\n##\n(\"entity\"<|>BELGIUM<|>GEO<|>A country in Europe that participates in healthcare practices and research related to parenteral nutrition.)\n##\n(\"entity\"<|>J PEDIATR GASTROENTEROL NUTR<|>ORGANIZATION<|>A journal that publishes research and reviews related to pediatric gastroenterology and nutrition, including studies on parenteral nutrition.)\n##\n(\"entity\"<|>J THROMB HAEMOST<|>ORGANIZATION<|>A journal focused on research related to thrombosis and hemostasis, including studies on complications associated with parenteral nutrition.)\n##\n(\"entity\"<|>NUTR CLIN PRACT<|>ORGANIZATION<|>A journal that publishes articles on clinical nutrition practices, including the risks and benefits of parenteral nutrition.)\n##\n(\"entity\"<|>JPEN J PARENTER ENTERAL NUTR<|>ORGANIZATION<|>A journal dedicated to research and clinical practices in parenteral and enteral nutrition.)\n##\n(\"entity\"<|>CRITICAL CARE<|>EVENT<|>A medical field focused on the treatment of life-threatening conditions, often involving patients receiving parenteral nutrition.)\n##\n(\"relationship\"<|>TASK FORCE FOR THE REVISION OF SAFE PRACTICES FOR PARENTERAL NUTRITION<|>INFECTIOUS DISEASES SOCIETY OF AMERICA<|>Both organizations contribute to the development of guidelines and safe practices for parenteral nutrition and infection control<|>7)\n##\n(\"relationship\"<|>SWITZERLAND<|>TASK FORCE FOR THE REVISION OF SAFE PRACTICES FOR PARENTERAL NUTRITION<|>Switzerland is involved in the practices and research related to parenteral nutrition as highlighted by the task force<|>5)\n##\n(\"relationship\"<|>FRANCE<|>TASK FORCE FOR THE REVISION OF SAFE PRACTICES FOR PARENTERAL NUTRITION<|>France participates in the task force's research and practices regarding parenteral nutrition<|>5)\n##\n(\"relationship\"<|>BELGIUM<|>TASK FORCE FOR THE REVISION OF SAFE PRACTICES FOR PARENTERAL NUTRITION<|>Belgium is involved in the task force's research and practices regarding parenteral nutrition<|>5)\n##\n(\"relationship\"<|>J PEDIATR GASTROENTEROL NUTR<|>TASK FORCE FOR THE REVISION OF SAFE PRACTICES FOR PARENTERAL NUTRITION<|>The journal publishes research relevant to the task force's guidelines on parenteral nutrition<|>6)\n##\n(\"relationship\"<|>J THROMB HAEMOST<|>TASK FORCE FOR THE REVISION OF SAFE PRACTICES FOR PARENTERAL NUTRITION<|>The journal includes studies on complications related to parenteral nutrition, relevant to the task force's work<|>6)\n##\n(\"relationship\"<|>NUTR CLIN PRACT<|>TASK FORCE FOR THE REVISION OF SAFE PRACTICES FOR PARENTERAL NUTRITION<|>The journal discusses clinical practices that align with the task force's guidelines on parenteral nutrition<|>6)\n##\n(\"relationship\"<|>JPEN J PARENTER ENTERAL NUTR<|>TASK FORCE FOR THE REVISION OF SAFE PRACTICES FOR PARENTERAL NUTRITION<|>The journal publishes articles that are relevant to the task force's focus on parenteral nutrition<|>6)\n##\n(\"relationship\"<|>CRITICAL CARE<|>TASK FORCE FOR THE REVISION OF SAFE PRACTICES FOR PARENTERAL NUTRITION<|>Critical care often involves patients receiving parenteral nutrition, making the task force's guidelines relevant<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: evidence and evidence deficit.\n      testinal failure. J Pediatr Gastroenterol Nutr. 2013;                Nurs Res Pract 2015; 2015:985686.\n      56:578-581.                                                     68.  Vidal E, Sharathkumar A, Glover J, Faustino EV.\n51.   Hellbock HJ, Motchnick PA, Ames BN. Toxic hydro-                     Central venosus catheter-related thrombosis and\n      peroxides in intravenous lipid emulsions used in                     thromboprophylasis in children: a systematic re-\n      preterm infants. Pediatrics. 1993; 91: 83-88.                        view and meta-analysis. J Thromb Haemost. 2014;\n52.   Task Force for the revision of safe practices for Pa-                12:1096-109.\n      renteral Nutrition. Safe practices for parenteral nu-           69.  Brandão LR, Shah N, Shah PS. Low molecular wei-\n      trition. JPENJ Parent Ent Nutr. 2004; 28: S1-S70.                    ght heparin for prevention of central venous ca-\n53.   Ball PA. Intravenous in-line filters: filtering the evi-             theterization-related thrombosis in children. Co-\n      dence. Curr Opin Clin Nutr Metab Care. 2003; 6:                      chrane Database Syst Rev. 2014; 3:CD005982.\n      319-325.                                                        70.  Kerner JA, Garcia-Careaga MG, Fisher AA, Poole\n54.   Blackmer AB, Partipilo ML. Three-in-One Parenteral                   RL. Treatment of catheter occlusion in pediatric\n      Nutrition in Neonates and Pediatric Patients: Risks                  patients.    JPEN    J   Parenter    Enteral     Nutr.   2006;\n      and Benefits. Nutr Clin Pract. 2015; 30:337-343.                     30:S73-S81.\n55.   Maisonneuve N, Raguso CA, Paolini-Giacobino A,                  71.  Mermel LA, Allon M, Bouza E, Craven DE, Flynn P,\n      et al.    Parenteral nutrition practices in Hospital                 O’Grady NP, et al. Clinical Practice Guidelines for\n      Pharmacies in Switzerland, France, and Belgium.                      the Diagnosis and Management of Intravascular\n      Nutrition. 2004; 20:528-35.                                          Catheter-Related Infection: 2009 Update by the\n---\n                                                Tema 55.      Nutrición parenteral en el paciente pediátrico: vías y fórmulas                 879\n\n\n\n     Infectious Diseases Society of America. Clin Infect                     82.   Rangel SJ, Calkns CM, Cowles RA, Barnhart DC,\n     Dis. 2009; 49:1-45.                                                           Huang      EY,   Abdullah     F  et   al.  Parenteral     nutri-\n72.  Janum      S,   Zingg     W,    Classsen      V,   Afshari    A.              tion-associated cholestasis: an American Pediatric\n     Bench-to-bedside review: challenges of diagnosis,                             Surgical Association Outcomes and Clinical Trials.\n     care and prevention of central catheter-realted                               Committee        systematic     review.     J  Pediatr    Surg.\n     bloodstream        infections     in   children.    Crit   Care.              2012; 47:225-40.\n     2013; 28:238.                                                           83.   Btaiche IF, Khalidi N. Metabolic complications of\n73.  Germán Díaz M, Moreno Villares JM; Gomis Mu-                                  parenteral nutrition in adults, part 2. Am J Heal-\n     ñoz P, León Sanz M. Sellado con antibióticos o                                th-SystPharm. 2004;61:2050-7; quiz 2058-9. Re-\n     antisépticos en pacientes pediátricos con nutrición                           view. Erratum in: Am J Health Syst Pharm. 2004;\n     parenteral domiciliaria. Puesta al día. Nutr Hosp.                            61:2616.\n     2016; 33:771-81.                                                        84.   Peyret B,    Collardeau S,       Touzet S,     Loras-Duclaux\n74.  Wong T, Clifford V, McCallum Z, et al. Central ve-                            I, Yantren H, Michalski MC, et al. Prevalence of li-\n     nous catheter thrombosis associated with 70%                                  ver  complications in children receiving long-term\n     ethanol locks in pediatric intestinal failure patients                        parenteral nutrition.       Eur J Clin Nutr. 2011 Jun;\n     on home parenteral nutrition: A case series. JPEN J                           65:743-9.\n     Parenter Enteral Nutr. 2011; 36:358-60.                                 85.   Forchielli ML, Walker WA. Nutritional factors con-\n75.  Bisseling TM, Willems MC, Versleijen MW,                  et al.              tributing to the development of cholestasis during\n     Taurolidine lock is highly effective in preventing ca-                        total   parenteral      nutrition.    Adv    Pediatr.\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}